299 related articles for article (PubMed ID: 34238020)
1. Cost-Utility of Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: An Economic Evaluation.
Lau D; Sandhu RK; Andrade JG; Ezekowitz J; So H; Klarenbach S
J Am Heart Assoc; 2021 Jul; 10(14):e019599. PubMed ID: 34238020
[TBL] [Abstract][Full Text] [Related]
2. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure With Reduced Ejection Fraction.
Chew DS; Loring Z; Anand J; Fudim M; Lowenstern A; Rymer JA; Weimer KED; Atwater BD; DeVore AD; Exner DV; Noseworthy PA; Yancy CW; Mark DB; Piccini JP
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007094. PubMed ID: 33280436
[TBL] [Abstract][Full Text] [Related]
3. Modelling the lifetime cost-effectiveness of catheter ablation for atrial fibrillation with heart failure.
Gao L; Moodie M
BMJ Open; 2019 Sep; 9(9):e031033. PubMed ID: 31492790
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of focal impulse and rotor modulation guided ablation added to pulmonary vein isolation for atrial fibrillation.
Baykaner T; Duff S; Hasegawa JT; Mafilios MS; Turakhia MP
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):526-536. PubMed ID: 29436112
[TBL] [Abstract][Full Text] [Related]
5. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis.
Perez A; Touchette DR; DiDomenico RJ; Stamos TD; Walton SM
Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439
[TBL] [Abstract][Full Text] [Related]
6. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base.
Chen Y; Gomes M; Garcia JV; Hunter RJ; Chow AW; Dhinoja M; Schilling RJ; Lowe M; Lambiase PD
Open Heart; 2020; 7(1):e001155. PubMed ID: 32076562
[TBL] [Abstract][Full Text] [Related]
9. [Cost-benefit analysis of concomitant atrial fibrillation management in Spain].
López Gude MJ; Rodríguez Bezos D; Rodríguez Barrios JM
Gac Sanit; 2010; 24(1):59-65. PubMed ID: 19931216
[TBL] [Abstract][Full Text] [Related]
10. A Long-Term Cost-Effectiveness Analysis Comparing Radiofrequency Catheter Ablation with Antiarrhythmic Drugs in Treatment of Chinese Patients with Atrial Fibrillation.
Du X; He X; Jia Y; Wu J; Long D; Yu R; Sang C; Yin H; Xuan J; Dong J; Ma C
Am J Cardiovasc Drugs; 2019 Dec; 19(6):569-577. PubMed ID: 31090018
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of catheter ablation versus medical therapy for the treatment of atrial fibrillation in the United Kingdom.
Leung LWM; Imhoff RJ; Marshall HJ; Frame D; Mallow PJ; Goldstein L; Wei T; Velleca M; Taylor H; Gallagher MM
J Cardiovasc Electrophysiol; 2022 Feb; 33(2):164-175. PubMed ID: 34897897
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of the convergent procedure and catheter ablation for non-paroxysmal atrial fibrillation.
Anderson LH; Black EJ; Civello KC; Martinson MS; Kress DC
J Med Econ; 2014 Jul; 17(7):481-91. PubMed ID: 24693987
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
Chew DS; Li Y; Cowper PA; Anstrom KJ; Piccini JP; Poole JE; Daniels MR; Monahan KH; Davidson-Ray L; Bahnson TD; Al-Khalidi HR; Lee KL; Packer DL; Mark DB;
Circulation; 2022 Aug; 146(7):535-547. PubMed ID: 35726631
[TBL] [Abstract][Full Text] [Related]
15. Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
AlTurki A; Proietti R; Dawas A; Alturki H; Huynh T; Essebag V
BMC Cardiovasc Disord; 2019 Jan; 19(1):18. PubMed ID: 30646857
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data.
Ming J; Wei Y; Sun H; Wong G; Yang G; Pong R; Chen Y
Value Health; 2019 Aug; 22(8):863-870. PubMed ID: 31426926
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom.
McKenna C; Palmer S; Rodgers M; Chambers D; Hawkins N; Golder S; Van Hout S; Pepper C; Todd D; Woolacott N
Heart; 2009 Apr; 95(7):542-9. PubMed ID: 19095714
[TBL] [Abstract][Full Text] [Related]
18. Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.
Nault I; Miyazaki S; Forclaz A; Wright M; Jadidi A; Jaïs P; Hocini M; Haïssaguerre M
Eur Heart J; 2010 May; 31(9):1046-54. PubMed ID: 20332181
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of cryoballoon ablation for the management of paroxysmal atrial fibrillation.
Reynolds MR; Lamotte M; Todd D; Khaykin Y; Eggington S; Tsintzos S; Klein G
Europace; 2014 May; 16(5):652-9. PubMed ID: 24390386
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial).
Hunter RJ; Berriman TJ; Diab I; Kamdar R; Richmond L; Baker V; Goromonzi F; Sawhney V; Duncan E; Page SP; Ullah W; Unsworth B; Mayet J; Dhinoja M; Earley MJ; Sporton S; Schilling RJ
Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):31-8. PubMed ID: 24382410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
